Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium

Area of Science:

• Cardiology
• Infectious Diseases
• Clinical Medicine

Background:

• Infective endocarditis (IE) presents ongoing diagnostic and therapeutic challenges despite advancements in medical technology.
• The epidemiology of IE has evolved, with older patient demographics and altered clinical presentations.
• Streptococci and staphylococci remain the predominant causative agents of infective endocarditis.

Purpose of the Study:

• To review the current understanding and management strategies for infective endocarditis (IE).
• To analyze trends and outcomes of IE based on clinical data and national registries.
• To evaluate the impact of diagnostic techniques, antibiotic regimens, and surgical interventions on IE mortality.

Main Methods:

• Review of clinical studies conducted in Göteborg since 1984.
• Analysis of data from the Swedish national registry of infective endocarditis (IE) since 1995.
• Comprehensive literature review on infective endocarditis.

Main Results:

• The incidence of IE in Sweden is approximately 6 per 100,000 inhabitants annually.
• Current IE patients are older, often present with fever as the primary symptom, and less frequently exhibit new heart murmurs.
• Standard antibiotic treatment (4-6 weeks) can reduce IE mortality to 30-50%; surgical intervention in 20-25% of cases further improves outcomes.

Conclusions:

• Optimal management of infective endocarditis (IE) involving rapid diagnosis, tailored antibiotic therapy, and timely surgery can decrease treatment-associated mortality to 10%.
• Antibiotic treatment for IE is largely empirical, with specific regimens recommended for different causative agents.
• Further research into optimizing antibiotic durations and combinations is warranted.